Home > Healthcare > Medical Devices > Diagnostic Devices > Blood Screening Market

Blood Screening Market Share

Report ID: GMI7618
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Blood Screening Market Share

The blood screening industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Abbott Laboratories, F. Hoffmann-La Roche Ltd., Grifols, S.A., Hologic, Inc., QIAGEN N.V., among others have a notable presence in the market.

Blood Screening Market Companies

Some of the eminent market participants operating in the blood screening industry include:

Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Grifols, S.A.
Hologic, Inc.
QIAGEN N.V.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Siemens Healthineers AG
Thermo Fisher Scientific, Inc.
SOFINA s.a (Biomerieux)
Danaher Corporation
Ortho-Clinical Diagnostics, Inc.
DiaSorin S.p.A.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Blood screening industry size was USD 3.2 billion in 2023 and is estimated to exceed USD 6.1 billion by 2032 due to the continual technological advancements, the rise in blood donation activities, increasing prevalence of infectious diseases and the growing healthcare infrastructure.

The reagents & kits product segment was around USD 2.4 billion revenue in 2023 owing to the growing focus on blood donation activities coupled with the higher automation and technology integration in the procedures.

Blood screening market size from blood banks segment exceeded USD 1.7 billion in 2023 due to the surging need for blood transfusions driven by the expanding ageing population.

North America blood screening industry size was USD 1.3 billion revenue in 2023 and is predicted to witness substantial growth up to 2032 propelled by the rising medical procedures, surgeries and trauma cases as well as the higher prevalence of chronic diseases.